How Can the Evolution of Trials & Guidelines in Pulmonary Hypertension Inform Future Efforts in IPF/ILD?
- Lessons from the evolution of endpoints in PH trials: from 6-minute walk test to composite and patient-centric outcomes
- Applicability of combination and sequential therapy strategies in IPF/ILD clinical development
- How changes in PH guidelines have influenced trial design – and what that could mean for future IPF/ILD guidance